LifeArc COVID-19 Fund
Coronavirus (COVID-19) therapeutics: £10 million call for rapid deployment
LifeArc has made available an initial £10M for the identification of therapeutics that can be rapidly deployed to treat COVID-19.
- To accelerate availability of treatments for patients
- Applicants will already have material available for testing and a plan for rapid scale up of clinical material.
- Priority will be given to projects that have a clear path and availability for patients in a 6-12 month timeframe.
Closing date: 6th April 2020